Plain-English answer
Medicine in China includes modern biomedicine, traditional Chinese medicine, public health, hospital-based specialty care, medical education, pharmaceuticals, medical devices, and state regulation. It should not be reduced either to ancient tradition or to current hospital medicine; the system contains both, with different evidence standards, institutions, and policy meanings.
Several medical traditions in one system
Chinese medicine has a long intellectual and clinical history, but the current health system is overwhelmingly shaped by modern hospitals, biomedical training, public health, insurance, and regulation. Traditional Chinese medicine remains institutionally important: China has TCM hospitals, TCM universities, TCM departments, herbal products, acupuncture services, and a national policy commitment to integrating Chinese and Western medicine. The National Library of Medicine's history materials emphasize that Chinese medical texts, materia medica, acupuncture diagrams, and commercial medical culture developed over centuries, but current TCM is also a modern institutional field with schools, hospitals, regulation, and commercial products.
The twentieth century changed the meaning of medicine in China. Public-health campaigns, mass vaccination, rural health workers, barefoot doctors, epidemic control, and patriotic health campaigns made medicine a state-building project. Modern biomedical hospitals expanded, and after reform and opening, advanced specialties, tertiary hospitals, devices, diagnostics, pharmaceuticals, and international research became central. The coexistence of TCM and biomedicine is therefore not a simple "old versus new" story. It is a policy settlement: preserve and modernize a national medical tradition while building a biomedical hospital and regulatory system.
Regulation makes the distinction practical. NMPA regulates drugs and medical devices, including product standards, registration, and postmarket supervision. TCM products face issues of quality control, standardization, safety, evidence, and international acceptance. Acupuncture and herbal medicine raise different questions from oncology drugs or AI devices. A serious page on medicine in China must therefore ask what kind of medicine is being discussed: clinical practice, historical tradition, public-health tool, pharmaceutical product, cultural identity, or regulated technology.
| Medical domain | Institutional setting | Key question |
|---|---|---|
| Biomedicine | Public hospitals, universities, clinical specialties, NMPA-regulated products. | What evidence, approval, reimbursement, and hospital adoption pathway applies? |
| Traditional Chinese medicine | TCM hospitals, universities, departments, pharmacies, and product manufacturers. | How are safety, quality, diagnosis, and evidence handled? |
| Public health | CDC functions, health commissions, campaigns, vaccination, surveillance, and local government. | Can the system prevent disease before hospital care is needed? |
Read medicine through institutions
The same word can refer to a practice, a profession, a hospital department, a regulated product, a cultural tradition, or a public-health campaign.
Institutional logic
Medicine in China is organized through hospitals, universities, professional societies, regulators, public-health agencies, and product markets. A TCM hospital, a tertiary cancer center, a village clinic, a China CDC surveillance unit, and an NMPA device review pathway all sit inside "medicine," but they answer different questions and use different evidence.
How it works
Patients may use biomedical hospitals, TCM services, community providers, pharmacies, internet hospitals, or self-care. TCM may be used as a primary therapy, adjunctive care, rehabilitation support, or cultural preference. Biomedical care dominates high-acuity hospital medicine, surgery, intensive care, oncology, imaging, and advanced diagnostics. The practical issue is not which tradition is symbolically important; it is which institution governs the specific care or product.
Evidence caution
Do not use one evidence standard for every question. Historical influence, cultural meaning, product safety, clinical efficacy, and reimbursement value are related but distinct claims.
How to read the issue
Identify the medical category
Separate historical practice, clinical service, drug, device, public-health program, and cultural policy.
Locate the institution
Ask whether the relevant actor is a hospital, TCM institution, regulator, university, payer, or public-health agency.
Check the evidence claim
Safety, efficacy, tradition, cost, acceptance, and access are different questions.
Strategic meaning
For cross-border readers, medicine in China is a reminder that clinical culture and institutional policy both matter. A biomedical product must navigate NMPA, reimbursement, hospital adoption, and evidence. A TCM product must navigate quality, safety, standardization, and credibility. A service model must fit hospital hierarchy, insurance, and patient trust.
Research anchors
| Anchor | Evidence | Implication |
|---|---|---|
| Historical tradition | National Library of Medicine documents traditional Chinese medical texts and historical materials. | TCM has deep historical roots but must be read through modern institutions. |
| Public-health history | Globalization and Health reviews public-health development in China from 1949 to 2019. | Modern Chinese medicine includes campaigns and state public-health capacity. |
| Product regulation | NMPA lists responsibilities for drugs, devices, standards, registration, and safety supervision. | Modern medical products are governed through regulatory pathways, not tradition alone. |